Friday, 15 October 2010 08:20
Veröffentlichungen im Jahr 2010
Publications in September
Besides interesting conferences like the ESB Meeting (European Conference on Biomaterials) from September 11 to 15 in Tampere, Finland many international articles about the application of chitosan appeared. As usual, some interesting papers will be presented.
Overview
In September 107 scientific papers dealing with chitosan or chitosan derivatives were published.
China is the country that hosts most scientists exploring the manifold applications of chitosan or characterizing this natural biopolymer. Chinese researchers published 32 papers in September. American scientist investigated in the fields of pharmaceutical and medical research and food technology, they published 9 articles like their Indian colleagues.
They are followed in regard of number of publications by Spanish and Canadian scientists with six articles each.
| Journal | Articles |
| AAPS PharmSciTech |
6 |
| J Hazard Mater | 5 |
| Biomacromolecules | 5 |
| Pharm Res | 5 |
| Carbohydr Res | 4 |
Source: www.gopubmed.org
Three publications in the fields of tissue engineering, drug delivery systems and cancer research will be presented below:
1. Abarrategi, Ander; Lopiz-Morales, Yaiza; Ramos, Viviana; Marco, Ferndo; Lopez Lacomba, Jose Luis: Chitosan scaffolds for osteochondral tissue regeneration. J Biomed Mater Res A, 2010.
Scientists from the University Complutense in Madrid, Spain investigated which parameters of chitosan are having an direct impact on osteochondral tissue regeneration.
The following parameters were manipulated: Molecular weight, degree of deacetylation and calcium content.
To identify the best parameter-combinations porous scaffolds were prepared and implanted in rabbit knees with osteochondral defects. After three months the animals were examined. Chitosan with the following parameter-combination regenerated best the osteochonral defects:
The following parameters were manipulated: Molecular weight, degree of deacetylation and calcium content.
To identify the best parameter-combinations porous scaffolds were prepared and implanted in rabbit knees with osteochondral defects. After three months the animals were examined. Chitosan with the following parameter-combination regenerated best the osteochonral defects:
- intact mineral content (17.9 wt %)
- low molecular weight (11.49 KDa) and
- low degree of deacetylation (83%)
2. Casettari, Luca; Vllasaliu, Driton; Mantovani, Guiseppe; Howdle, Steven M..; Stolnik, Snow, Illum, Lisbeth: Effect of PEGylation on the Toxicity and Permeability Enhancement of Chitosan. Biomacromolecules, 2010.
The research-team of Lisbeth Illum presents results showing how PEGylation can influence toxicity and permeability of tight junctions in nasal applications.
In nasal mucosa chitosan is able to open cellular tight junctions and thus enables the permeability of macromolecules. Tests were perfomed with Calu-3 monolayers.
Results:
- reduction of toxicity
- enhancement of permeability of macromolecules, pH-dependent
- positive effects on cell monolayer transepithelial electrical resistance, pH-dependent
3. Leung, Matthew; Kievit, Forrest M.; Florczyk, Stephen J.; Veiseh, Omid; Wu, Jennifer; Park, James O.; Zhang, Miqin: Chitosan-alginate scaffold culture system for hepatocellular carcinoma increases malignancy and drug resistance. Pharm Res, 2010.
Aim of the work was the development of a 3D in vitro HCC model. Therefore a chitosan-alginate scaffold was cultured with human HCC cell lines.
Hepatocellular carcinoma (HCC) is a prevalent tumour. Its investigation and combat so far has been hampered by a lack of in vitro cell culture systems similar to the in vivo tumour microenvironment. The scaffolds were produced from chitosan and alginate and tested in vivo and in vitro.
The following observations were made:
Hepatocellular carcinoma (HCC) is a prevalent tumour. Its investigation and combat so far has been hampered by a lack of in vitro cell culture systems similar to the in vivo tumour microenvironment. The scaffolds were produced from chitosan and alginate and tested in vivo and in vitro.
The following observations were made:
- Good growth of the cell lines on the scaffolds with typical morphology and a high number of malign cells.
- In vivo: acceleration of tumour growth.
- Influence on the formation (morphology and organisation) of new blood vessels.
Find more news about Chitosan here.
You have a question concerning the application of chitosan or you want to order chitosan? Please send us your
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Source: GoPubMed; Search: Chitosan, limits: September 2010, State: 15.11.2010.
